ACE2 and chronic obstructive pulmonary disease: In addition, a recent study reported that inhaled corticosteroids (ICS), which are treatment options for COPD patients, downregulated the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon [13].